{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:09:30Z","timestamp":1776805770160,"version":"3.51.2"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1038\/3293","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:54Z","timestamp":1027673034000},"page":"1302-1307","source":"Crossref","is-referenced-by-count":838,"title":["Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry"],"prefix":"10.1038","volume":"4","author":[{"given":"J. Michael","family":"Kilby","sequence":"first","affiliation":[]},{"given":"Sam","family":"Hopkins","sequence":"additional","affiliation":[]},{"given":"Thomas M.","family":"Venetta","sequence":"additional","affiliation":[]},{"given":"Betty","family":"DiMassimo","sequence":"additional","affiliation":[]},{"given":"Gretchen A.","family":"Cloud","sequence":"additional","affiliation":[]},{"given":"Jeannette Y.","family":"Lee","sequence":"additional","affiliation":[]},{"given":"Leslie","family":"Alldredge","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Hunter","sequence":"additional","affiliation":[]},{"given":"Dennis","family":"Lambert","sequence":"additional","affiliation":[]},{"given":"Dani","family":"Bolognesi","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Matthews","sequence":"additional","affiliation":[]},{"given":"M. Ross","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Martin A.","family":"Nowak","sequence":"additional","affiliation":[]},{"given":"George M.","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Michael S.","family":"Saag","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnm1198_1302_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jama.280.1.78","volume":"280","author":"CC Carpenter","year":"1998","unstructured":"Carpenter, C.C. et al. Anti-retroviral therapy for HIV infection in 1998. J. Am. Med. Assoc. 280, 78\u201386 (1998).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm1198_1302_CR2","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1056\/NEJM199512213332502","volume":"333","author":"JJ Eron","year":"1995","unstructured":"Eron, J.J. et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. N. Engl. J. Med. 333, 1662\u20139 ( 1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1198_1302_CR3","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1056\/NEJM199512073332204","volume":"333","author":"M Markowitz","year":"1995","unstructured":"Markowitz, M. et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N. Engl. J. Med. 333, 1534\u20139 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1198_1302_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJM199709113371101","volume":"337","author":"S Hammer","year":"1997","unstructured":"Hammer, S. et al. A randomized, placebo-controlled trial of indinavir in combination with two nucleoside analogs in HIV-infected persons with CD4 cell counts less than or equal to 200 per cubic millimeter. N. Engl. J. Med. 337, 725 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1198_1302_CR5","doi-asserted-by":"crossref","unstructured":"Saag, M.S. Nucleoside analogs: adverse effects. Hosp. Pract. 27 (supp), 26-36 (1992).","DOI":"10.1080\/21548331.1992.11705597"},{"key":"BFnm1198_1302_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/archinte.1997.00440300037003","volume":"157","author":"CK McDonald","year":"1997","unstructured":"McDonald, C.K. & Kuritzkes, D.R. HIV-1 protease inhibitors. Arch. Intern. Med. 157, 951\u2013959 (1997).","journal-title":"Arch. Intern. Med."},{"key":"BFnm1198_1302_CR7","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1128\/AAC.37.6.1207","volume":"37","author":"DD Richman","year":"1993","unstructured":"Richman, D.D. Resistance of clinical isolates of HIV to anti-retroviral agents. Antimicrob. Agents Chemother. 37, 1207\u2013 1213 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnm1198_1302_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/374569a0","volume":"374","author":"JH Condra","year":"1995","unstructured":"Condra, J.H. et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569\u2013 71 (1995).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/31405","volume":"393","author":"PD Kwong","year":"1998","unstructured":"Kwong, P.D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648\u2013659 ( 1998).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","volume":"89","author":"DC Chan","year":"1997","unstructured":"Chan, D.C., Fass, D., Berger, J.M. & Kim, P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263\u201373 (1997).","journal-title":"Cell"},{"key":"BFnm1198_1302_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/aid.1989.5.431","volume":"5","author":"W Gallaher","year":"1989","unstructured":"Gallaher, W., Ball, J., Garry, R., Griffin, M. & Montelaro R. A general model of the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5, 431\u201340 (1989).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm1198_1302_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/aid.1990.6.703","volume":"6","author":"E Delwart","year":"1989","unstructured":"Delwart, E., Mosialos, G. & Gilmore, T. Retroviral envelope glycoproteins contain a \"leucine zipper\"-like repeat. AIDS Res. Hum. Retroviruses 6, 703\u20136 (1989).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm1198_1302_CR13","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1128\/JVI.69.6.3771-3777.1995","volume":"69","author":"CH Chen","year":"1995","unstructured":"Chen, C.H., Matthews, T., McDanal, C., Bolognesi, D. & Greenberg M. A molecular clasp in HIV-1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69, 3771\u20137 ( 1995).","journal-title":"J. Virol."},{"key":"BFnm1198_1302_CR14","doi-asserted-by":"publisher","first-page":"13697","DOI":"10.1021\/bi9606962","volume":"35","author":"MK Lawless","year":"1996","unstructured":"Lawless, M.K. et al. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry 35, 13697\u2013708 ( 1996).","journal-title":"Biochemistry"},{"key":"BFnm1198_1302_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-065X.1994.tb00866.x","volume":"140","author":"T Matthews","year":"1994","unstructured":"Matthews, T. et al. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140, 93\u2013104 (1994).","journal-title":"Immunol. Rev."},{"key":"BFnm1198_1302_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/aid.1995.11.323","volume":"11","author":"C Wild","year":"1995","unstructured":"Wild, C., Greenwell, T., Shugars, D., Rimsky-Clarke & Matthews T. The inhibitory activity of an HIV-1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11, 323\u20135 (1995).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm1198_1302_CR17","doi-asserted-by":"publisher","first-page":"10537","DOI":"10.1073\/pnas.89.21.10537","volume":"89","author":"C Wild","year":"1992","unstructured":"Wild C., Oas T., McDanal C., Bolognesi D. & Matthews T. A synthetic peptide inhibitor of HIV replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537\u201341 ( 1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR18","doi-asserted-by":"publisher","first-page":"12303","DOI":"10.1073\/pnas.94.23.12303","volume":"94","author":"K Tan","year":"1997","unstructured":"Tan, K., Liu, J.H., Want, J.H., Shen, S., & Lu, M. Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94, 12303\u2013308 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/387426a0","volume":"387","author":"WA Weissenhorn","year":"1997","unstructured":"Weissenhorn, W.A., Dessen, A., Harrison, S.C., Skehel, J.J. & Wiley, D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426\u2013 30 (1997).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR20","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/JVI.66.8.4748-4756.1992","volume":"66","author":"J Dubay","year":"1992","unstructured":"Dubay, J., Roberts, S., Brody, B. & Hunter, E. Mutations in the leucine zipper of HIV-1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748\u201356 (1992).","journal-title":"J. Virol."},{"key":"BFnm1198_1302_CR21","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1073\/pnas.91.26.12676","volume":"91","author":"C Wild","year":"1994","unstructured":"Wild, C. et al. Propensity for a leucine zipper-like domain of HIV-1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA 91, 12676\u201380 ( 1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR22","first-page":"37","volume":"371","author":"PA Bullough","year":"1994","unstructured":"Bullough, P.A., Hughson, M., Skehel, J.J. & Wiley, D.C. Structure of influena haemagglutinin at the pH of membrane fusion. J. Virol. 371, 37\u201343 ( 1994).","journal-title":"J. Virol."},{"key":"BFnm1198_1302_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0092-8674(93)90260-W","volume":"73","author":"C Carr","year":"1993","unstructured":"Carr, C. & Kim, P.S. A spring-loaded mechanism for the conformational change of influenza hemaglutinin. Cell 73, 823\u201332 (1993).","journal-title":"Cell"},{"key":"BFnm1198_1302_CR24","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1089\/aid.1993.9.1051","volume":"9","author":"C Wild","year":"1993","unstructured":"Wild, C., Greenwell, T. & Matthews, T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 9, 1051\u20133 (letter) ( 1993).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm1198_1302_CR25","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","volume":"91","author":"CT Wild","year":"1994","unstructured":"Wild, C.T., Shugars, D.C., Greenwell, T.K., McDanal, C.B. & Matthews, T.J. Peptides corresponding to a predictive alpha-helical domain of HIV-1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770\u2013 4 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/JVI.72.2.986-993.1998","volume":"72","author":"LT Rimsky","year":"1998","unstructured":"Rimsky, L.T., Shugars, D.C. & Matthews, T. Determinants of HIV-1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986\u2013 992 (1998).","journal-title":"J. Virol."},{"key":"BFnm1198_1302_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/373117a0","volume":"373","author":"X Wei","year":"1995","unstructured":"Wei, X, et al. Viral dynamics in HIV-1 infection. Nature 373, 117\u201322 (1995).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/373123a0","volume":"373","author":"DD Ho","year":"1995","unstructured":"Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123\u2013 26 (1995).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR29","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1073\/pnas.93.14.7247","volume":"93","author":"AVM Herz","year":"1996","unstructured":"Herz, A.V.M., Bonhoeffer, S., Anderson, R.M., May, R.M. & Nowak, M.A. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc. Natl. Acad. Sci. USA 93, 7247\u201351 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR30","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. & Ho, D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582\u201386 ( 1996).","journal-title":"Science"},{"key":"BFnm1198_1302_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/jama.279.12.930","volume":"279","author":"JSG Montaner","year":"1998","unstructured":"Montaner, J.S.G. et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. J. Am. Med. Assoc. 279, 930\u201337 (1998).","journal-title":"J. Am. Med. Assoc."},{"key":"BFnm1198_1302_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1006\/jtbi.1996.0307","volume":"184","author":"MA Nowak","year":"1997","unstructured":"Nowak, M.A., Bonhoeffer, S., Shaw, G.M. & May, R.M. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. J. Theor. Biol. 184, 203 \u201317 (1997).","journal-title":"J. Theor. Biol."},{"key":"BFnm1198_1302_CR33","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1073\/pnas.94.13.6971","volume":"94","author":"S Bonhoeffer","year":"1997","unstructured":"Bonhoeffer, S., May, R.M., Shaw, G.M. & Nowak, M.A. Virus dynamics and drug treatment. Proc. Natl. Acad. Sci. USA 94, 6971\u201376 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/387188a0","volume":"387","author":"AS Perelson","year":"1997","unstructured":"Perelson, A.S. et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188\u2013191 (1997).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR35","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1073\/pnas.85.16.6132","volume":"85","author":"M Baba","year":"1988","unstructured":"Baba, M. et al. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of HIV in vitro. Proc. Natl. Acad. Sci. USA 85, 6132\u201336 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1198_1302_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1126\/science.2452480","volume":"240","author":"H Mitsuya","year":"1988","unstructured":"Mitsuya, H. et al. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science 240, 646\u201348 (1988).","journal-title":"Science"},{"key":"BFnm1198_1302_CR37","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1128\/AAC.35.12.2544","volume":"35","author":"C Flexner","year":"1991","unstructured":"Flexner, C. et al. Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in HIV infection. Antimicrob. Agents Chemother. 35, 2544\u201350 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnm1198_1302_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/331076a0","volume":"331","author":"RA Fisher","year":"1988","unstructured":"Fisher, R.A. et al. HIV infection is blocked in vitro by recombinant soluble CD4. Nature 331, 76\u201378 (1988).","journal-title":"Nature"},{"key":"BFnm1198_1302_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-112-4-247","volume":"112","author":"RT Schooley","year":"1990","unstructured":"Schooley, R.T. et al. Recombinant soluble CD4 therapy in patients with AIDS and AIDS-related complex. Ann. Intern. Med. 112, 247\u201353 (1990).","journal-title":"Ann. Intern. Med."},{"key":"BFnm1198_1302_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/00042560-199502000-00006","volume":"8","author":"TC Meng","year":"1995","unstructured":"Meng, T.C. et al. Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8, 152\u2013160 (1995).","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"BFnm1198_1302_CR41","unstructured":"Shacker, T. et al. Phase I study of high-dose, intravenous rsCD4 in subjects with advanced HIV-1 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9145\u2013152 ( 1995)."},{"key":"BFnm1198_1302_CR42","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/nm1097-1110","volume":"3","author":"JD Chen","year":"1997","unstructured":"Chen, J.D., Bai, X., Yang, A.G., Cong, Y. & Chen, S.Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nature Med. 3, 1110\u20131116 (1997).","journal-title":"Nature Med."},{"key":"BFnm1198_1302_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nm0198-072","volume":"4","author":"GA Donzella","year":"1998","unstructured":"Donzella, G.A. et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Med. 4, 72\u2013 77 (1998).","journal-title":"Nature Med."},{"key":"BFnm1198_1302_CR44","doi-asserted-by":"publisher","first-page":"44043","DOI":"10.2337\/diab.46.3.440","volume":"46","author":"B Zinman","year":"1997","unstructured":"Zinman, B., Tildesley, H., Chiasson, J.L., Tsui, E. & Strack, T. Insulin Lispro in CSII: results of a double-blind crossover study. Diabetes 46, 44043 (1997).","journal-title":"Diabetes"},{"key":"BFnm1198_1302_CR45","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00042560-199504120-00003","volume":"8","author":"C Pachl","year":"1995","unstructured":"Pachl, C. et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay . J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8, 446\u201354 (1995).","journal-title":". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"BFnm1198_1302_CR46","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/aid.1995.11.353","volume":"11","author":"Y Cao","year":"1995","unstructured":"Cao, Y. et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res. Hum. Retroviruses 11, 353\u201361 (1995).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFnm1198_1302_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00042560-199702010-00013","volume":"14","author":"GA Schockmel","year":"1997","unstructured":"Schockmel, G.A., Yerly, S. & Perrin, L. Detection of low HIV-1 levels in plasma. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 179 \u201383 (1997).","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"BFnm1198_1302_CR48","unstructured":"SAS\/STAT User's Guide Version 6, 4th edn., Vol. 1 & 2 (SAS Institute, Cary, North Carolina, 1989 )."},{"key":"BFnm1198_1302_CR49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","volume":"93","author":"DC Chan","year":"1998","unstructured":"Chan, D. C. and Kim P. S. HIV Entry and Its Inhibition. Cell 93, 681\u201384 ( 1998).","journal-title":"Cell"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1302","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1198_1302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:15:17Z","timestamp":1684448117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1198_1302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["BFnm1198_1302"],"URL":"https:\/\/doi.org\/10.1038\/3293","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}